 | • レポートコード：MRC2Q12-18338 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、弁膜症用機器のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 弁膜症用機器のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 弁膜症用機器の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 弁膜症用機器のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの弁膜症用機器の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の弁膜症用機器の売上および2028年までの予測に焦点を当てています。 弁膜症用機器のグローバル主要企業には、Edwards Lifesciences、Medtronic、Abbott、Boston Scientific、Venus Medtech、Meril Life Sciences、Braile Biomedicaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 弁膜症用機器市場は、タイプとアプリケーションによって区分されます。世界の弁膜症用機器市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 TAVR、TPVR、TMVR 【アプリケーション別セグメント】 病院、外来手術センター、心臓カテーテル研究所 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 弁膜症用機器製品概要 - タイプ別市場（TAVR、TPVR、TMVR） - アプリケーション別市場（病院、外来手術センター、心臓カテーテル研究所） - 調査の目的 ・エグゼクティブサマリー - 世界の弁膜症用機器販売量予測2017-2028 - 世界の弁膜症用機器売上予測2017-2028 - 弁膜症用機器の地域別販売量 - 弁膜症用機器の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別弁膜症用機器販売量 - 主要メーカー別弁膜症用機器売上 - 主要メーカー別弁膜症用機器価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（TAVR、TPVR、TMVR） - 弁膜症用機器のタイプ別販売量 - 弁膜症用機器のタイプ別売上 - 弁膜症用機器のタイプ別価格 ・アプリケーション別市場規模（病院、外来手術センター、心臓カテーテル研究所） - 弁膜症用機器のアプリケーション別販売量 - 弁膜症用機器のアプリケーション別売上 - 弁膜症用機器のアプリケーション別価格 ・北米市場 - 北米の弁膜症用機器市場規模（タイプ別、アプリケーション別） - 主要国別の弁膜症用機器市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの弁膜症用機器市場規模（タイプ別、アプリケーション別） - 主要国別の弁膜症用機器市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の弁膜症用機器市場規模（タイプ別、アプリケーション別） - 主要国別の弁膜症用機器市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の弁膜症用機器市場規模（タイプ別、アプリケーション別） - 主要国別の弁膜症用機器市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの弁膜症用機器市場規模（タイプ別、アプリケーション別） - 主要国別の弁膜症用機器市場規模（トルコ、サウジアラビア） ・企業情報 Edwards Lifesciences、Medtronic、Abbott、Boston Scientific、Venus Medtech、Meril Life Sciences、Braile Biomedica ・産業チェーン及び販売チャネル分析 - 弁膜症用機器の産業チェーン分析 - 弁膜症用機器の原材料 - 弁膜症用機器の生産プロセス - 弁膜症用機器の販売及びマーケティング - 弁膜症用機器の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 弁膜症用機器の産業動向 - 弁膜症用機器のマーケットドライバー - 弁膜症用機器の課題 - 弁膜症用機器の阻害要因 ・主な調査結果 |
It is a market trend for patients to choose valvular disease interventional devices, such as TAVR and TMVr systems, which provide alternative options with lower risk and more rapid recovery.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Valvular Disease Device is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Valvular Disease Device is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Valvular Disease Device is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Valvular Disease Device include Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, Venus Medtech, Meril Life Sciences and Braile Biomedica, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Valvular Disease Device manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Valvular Disease Device market. Further, it explains the major drivers and regional dynamics of the global Valvular Disease Device market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Edwards Lifesciences
Medtronic
Abbott
Boston Scientific
Venus Medtech
Meril Life Sciences
Braile Biomedica
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Valvular Disease Device Segment by Type
TAVR
TPVR
TMVR
Valvular Disease Device Segment by Application
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratory
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Valvular Disease Device market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Valvular Disease Device, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Valvular Disease Device, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Valvular Disease Device, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Valvular Disease Device sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Valvular Disease Device market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Valvular Disease Device sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, Venus Medtech, Meril Life Sciences and Braile Biomedica, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Valvular Disease Device in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Valvular Disease Device manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Valvular Disease Device sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Valvular Disease Device Product Introduction
1.2 Market by Type
1.2.1 Global Valvular Disease Device Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 TAVR
1.2.3 TPVR
1.2.4 TMVR
1.3 Market by Application
1.3.1 Global Valvular Disease Device Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Cardiac Catheterization Laboratory
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Valvular Disease Device Sales Estimates and Forecasts 2017-2028
2.2 Global Valvular Disease Device Revenue Estimates and Forecasts 2017-2028
2.3 Global Valvular Disease Device Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Valvular Disease Device Sales by Region
2.4.1 Global Valvular Disease Device Sales by Region (2017-2022)
2.4.2 Global Sales Valvular Disease Device by Region (2023-2028)
2.5 Global Valvular Disease Device Revenue by Region
2.5.1 Global Valvular Disease Device Revenue by Region (2017-2022)
2.5.2 Global Valvular Disease Device Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Valvular Disease Device Sales by Manufacturers
3.1.1 Global Top Valvular Disease Device Manufacturers by Sales (2017-2022)
3.1.2 Global Valvular Disease Device Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Valvular Disease Device in 2021
3.2 Global Valvular Disease Device Revenue by Manufacturers
3.2.1 Global Valvular Disease Device Revenue by Manufacturers (2017-2022)
3.2.2 Global Valvular Disease Device Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Valvular Disease Device Revenue in 2021
3.3 Global Valvular Disease Device Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Valvular Disease Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Valvular Disease Device Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Valvular Disease Device Sales by Type
4.1.1 Global Valvular Disease Device Historical Sales by Type (2017-2022)
4.1.2 Global Valvular Disease Device Forecasted Sales by Type (2023-2028)
4.1.3 Global Valvular Disease Device Sales Market Share by Type (2017-2028)
4.2 Global Valvular Disease Device Revenue by Type
4.2.1 Global Valvular Disease Device Historical Revenue by Type (2017-2022)
4.2.2 Global Valvular Disease Device Forecasted Revenue by Type (2023-2028)
4.2.3 Global Valvular Disease Device Revenue Market Share by Type (2017-2028)
4.3 Global Valvular Disease Device Price by Type
4.3.1 Global Valvular Disease Device Price by Type (2017-2022)
4.3.2 Global Valvular Disease Device Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Valvular Disease Device Sales by Application
5.1.1 Global Valvular Disease Device Historical Sales by Application (2017-2022)
5.1.2 Global Valvular Disease Device Forecasted Sales by Application (2023-2028)
5.1.3 Global Valvular Disease Device Sales Market Share by Application (2017-2028)
5.2 Global Valvular Disease Device Revenue by Application
5.2.1 Global Valvular Disease Device Historical Revenue by Application (2017-2022)
5.2.2 Global Valvular Disease Device Forecasted Revenue by Application (2023-2028)
5.2.3 Global Valvular Disease Device Revenue Market Share by Application (2017-2028)
5.3 Global Valvular Disease Device Price by Application
5.3.1 Global Valvular Disease Device Price by Application (2017-2022)
5.3.2 Global Valvular Disease Device Price Forecast by Application (2023-2028)
6 North America
6.1 North America Valvular Disease Device Market Size by Type
6.1.1 North America Valvular Disease Device Sales by Type (2017-2028)
6.1.2 North America Valvular Disease Device Revenue by Type (2017-2028)
6.2 North America Valvular Disease Device Market Size by Application
6.2.1 North America Valvular Disease Device Sales by Application (2017-2028)
6.2.2 North America Valvular Disease Device Revenue by Application (2017-2028)
6.3 North America Valvular Disease Device Market Size by Country
6.3.1 North America Valvular Disease Device Sales by Country (2017-2028)
6.3.2 North America Valvular Disease Device Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Valvular Disease Device Market Size by Type
7.1.1 Europe Valvular Disease Device Sales by Type (2017-2028)
7.1.2 Europe Valvular Disease Device Revenue by Type (2017-2028)
7.2 Europe Valvular Disease Device Market Size by Application
7.2.1 Europe Valvular Disease Device Sales by Application (2017-2028)
7.2.2 Europe Valvular Disease Device Revenue by Application (2017-2028)
7.3 Europe Valvular Disease Device Market Size by Country
7.3.1 Europe Valvular Disease Device Sales by Country (2017-2028)
7.3.2 Europe Valvular Disease Device Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Valvular Disease Device Market Size by Type
8.1.1 Asia Pacific Valvular Disease Device Sales by Type (2017-2028)
8.1.2 Asia Pacific Valvular Disease Device Revenue by Type (2017-2028)
8.2 Asia Pacific Valvular Disease Device Market Size by Application
8.2.1 Asia Pacific Valvular Disease Device Sales by Application (2017-2028)
8.2.2 Asia Pacific Valvular Disease Device Revenue by Application (2017-2028)
8.3 Asia Pacific Valvular Disease Device Market Size by Region
8.3.1 Asia Pacific Valvular Disease Device Sales by Region (2017-2028)
8.3.2 Asia Pacific Valvular Disease Device Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Valvular Disease Device Market Size by Type
9.1.1 Latin America Valvular Disease Device Sales by Type (2017-2028)
9.1.2 Latin America Valvular Disease Device Revenue by Type (2017-2028)
9.2 Latin America Valvular Disease Device Market Size by Application
9.2.1 Latin America Valvular Disease Device Sales by Application (2017-2028)
9.2.2 Latin America Valvular Disease Device Revenue by Application (2017-2028)
9.3 Latin America Valvular Disease Device Market Size by Country
9.3.1 Latin America Valvular Disease Device Sales by Country (2017-2028)
9.3.2 Latin America Valvular Disease Device Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Valvular Disease Device Market Size by Type
10.1.1 Middle East and Africa Valvular Disease Device Sales by Type (2017-2028)
10.1.2 Middle East and Africa Valvular Disease Device Revenue by Type (2017-2028)
10.2 Middle East and Africa Valvular Disease Device Market Size by Application
10.2.1 Middle East and Africa Valvular Disease Device Sales by Application (2017-2028)
10.2.2 Middle East and Africa Valvular Disease Device Revenue by Application (2017-2028)
10.3 Middle East and Africa Valvular Disease Device Market Size by Country
10.3.1 Middle East and Africa Valvular Disease Device Sales by Country (2017-2028)
10.3.2 Middle East and Africa Valvular Disease Device Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Edwards Lifesciences
11.1.1 Edwards Lifesciences Corporation Information
11.1.2 Edwards Lifesciences Overview
11.1.3 Edwards Lifesciences Valvular Disease Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Edwards Lifesciences Valvular Disease Device Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Edwards Lifesciences Recent Developments
11.2 Medtronic
11.2.1 Medtronic Corporation Information
11.2.2 Medtronic Overview
11.2.3 Medtronic Valvular Disease Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Medtronic Valvular Disease Device Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Medtronic Recent Developments
11.3 Abbott
11.3.1 Abbott Corporation Information
11.3.2 Abbott Overview
11.3.3 Abbott Valvular Disease Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Abbott Valvular Disease Device Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Abbott Recent Developments
11.4 Boston Scientific
11.4.1 Boston Scientific Corporation Information
11.4.2 Boston Scientific Overview
11.4.3 Boston Scientific Valvular Disease Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Boston Scientific Valvular Disease Device Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Boston Scientific Recent Developments
11.5 Venus Medtech
11.5.1 Venus Medtech Corporation Information
11.5.2 Venus Medtech Overview
11.5.3 Venus Medtech Valvular Disease Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Venus Medtech Valvular Disease Device Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Venus Medtech Recent Developments
11.6 Meril Life Sciences
11.6.1 Meril Life Sciences Corporation Information
11.6.2 Meril Life Sciences Overview
11.6.3 Meril Life Sciences Valvular Disease Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Meril Life Sciences Valvular Disease Device Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Meril Life Sciences Recent Developments
11.7 Braile Biomedica
11.7.1 Braile Biomedica Corporation Information
11.7.2 Braile Biomedica Overview
11.7.3 Braile Biomedica Valvular Disease Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Braile Biomedica Valvular Disease Device Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Braile Biomedica Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Valvular Disease Device Industry Chain Analysis
12.2 Valvular Disease Device Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Valvular Disease Device Production Mode & Process
12.4 Valvular Disease Device Sales and Marketing
12.4.1 Valvular Disease Device Sales Channels
12.4.2 Valvular Disease Device Distributors
12.5 Valvular Disease Device Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Valvular Disease Device Industry Trends
13.2 Valvular Disease Device Market Drivers
13.3 Valvular Disease Device Market Challenges
13.4 Valvular Disease Device Market Restraints
14 Key Findings in The Global Valvular Disease Device Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer